Results 51 to 60 of about 6,475 (230)

Claustrum Sign in Hashimoto Encephalopathy Presenting With New Onset Refractory Status Epilepticus (NORSE): First Report of a Rare Phenotype

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT The presence of the bilateral claustrum sign in new‐onset refractory status epilepticus (NORSE) should prompt consideration of Hashimoto's encephalopathy, even without thyroid dysfunction. Early recognition and corticosteroid therapy can be lifesaving, emphasizing an autoimmune‐inflammatory mechanism underlying this rare presentation.
Zahra‐Sadat Mirian   +4 more
wiley   +1 more source

Model predictive control for the prescription of antithyroid agents

open access: yes, 2023
2 ...
Menzel, Maylin   +3 more
openaire   +2 more sources

Clinical Usefulness of TSH Receptor Autoantibody Using Different Assay Systems [PDF]

open access: yes, 2011
Thyroid stimulating hormone receptor antibody (TRAb) plays an important role in Graves' disease (GD). A second-generation measurement system has been developed and we have gotten a benefit by the system clinically. In this study, we determined 4 kinds of
Mimura, Yukari   +2 more
core   +1 more source

Withania somnifera Root Extract Ameliorates PTU‐Induced Hypothyroidism by Regulating Hormone Levels and Gene Expression in Rats

open access: yesFood Science &Nutrition, Volume 14, Issue 4, April 2026.
Graphical abstract for the integrated in silico and in vivo approach demonstrating the Methanolic extract of Withania somnifera root ameliorated PTU‐induced hypothyroidism through the regulation of thyroid hormone levels, gene expression, and thyroid histopathology.
Md. Saud Hossain   +7 more
wiley   +1 more source

Antithyroid drug-induced agranulocytosis [PDF]

open access: yes, 1999
Thyrotoxicosis is a common endocrine disorder. Antithyroid drug therapy is the standard treatment for this disease, especially in young women of reproductive age. A serious side effect of antithyroid drug use, however, is agranulocytosis.
Lee, CH, Liang, RHS
core  

Kisspeptin Restores Placental mTOR Signaling and Improves Glucose Homeostasis Mediators Disrupted by Maternal Hypothyroidism in Rats

open access: yesActa Physiologica, Volume 242, Issue 4, April 2026.
ABSTRACT Aim Reduced placental mTOR signaling is associated with intrauterine growth restriction and impaired maternal and placental metabolism. Since maternal hypothyroidism induces intrauterine growth restriction, and maternal treatment with kisspeptin‐10 (Kp10) has been shown to improve feto‐placental development in hypothyroid rats, this study ...
Bianca Reis Santos   +9 more
wiley   +1 more source

Sequential Amiodarone‐Induced Thyroid Dysfunction: From Myxedema Coma to Late‐Onset Type 1 Thyrotoxicosis After Drug Withdrawal

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Amiodarone therapy may induce thyroid dysfunction in approximately 20% of patients, either amiodarone‐induced hypothyroidism (AIH) or thyrotoxicosis (AIT). Both situations may occur at any time during treatment or even months to years after drug withdrawal due to tissue storage with slow systemic release.
Daniela M. Soares, Lia Ferreira
wiley   +1 more source

Thyrotoxic Periodic Paralysis—A Misleading Challenge in the Emergency Department

open access: yesDiagnostics, 2020
Despite its’ life-threatening potential due to cardiac severe dysrhythmia in the context of severe hypokalemia, thyrotoxic periodic paralysis (TPP) often goes unrecognized.
Stefana Bilha   +4 more
doaj   +1 more source

Graves' Disease: Can It Be Cured? [PDF]

open access: yesEndocrinology and Metabolism, 2019
Whether or not Graves' hyperthyroidism can be really cured, depends on the definition of “cure.” If eradication of thyroid hormone excess suffices for the label “cure,” then all patients can be cured because total thyroidectomy or high doses of 131I will
Wilmar M. Wiersinga
doaj   +1 more source

Cholestatic jaundice caused by sequential carbimazole and propylthiouracil treatment for thyrotoxicosis [PDF]

open access: yes, 2003
A 36-year-old Chinese man presented to the Queen Mary Hospital in August 1999 with a 2-week history of jaundice due to propylthiouracil treatment for thyrotoxicosis. He had previously received carbimazole but had developed an urticarial skin rash after 2
Chan, AOO   +4 more
core  

Home - About - Disclaimer - Privacy